These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 16963545

  • 1. Pharmacotherapy for mortality reduction in chronic obstructive pulmonary disease.
    Sin DD, Man SF.
    Proc Am Thorac Soc; 2006 Sep; 3(7):624-9. PubMed ID: 16963545
    [Abstract] [Full Text] [Related]

  • 2. The impact of inhaled corticosteroid and long-acting beta-agonist combination therapy on outcomes in COPD.
    Hanania NA.
    Pulm Pharmacol Ther; 2008 Sep; 21(3):540-50. PubMed ID: 18280761
    [Abstract] [Full Text] [Related]

  • 3. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
    Baker WL, Baker EL, Coleman CI.
    Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
    [Abstract] [Full Text] [Related]

  • 4. The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding.
    Tashkin DP.
    Am J Med; 2006 Oct; 119(10 Suppl 1):63-72. PubMed ID: 16996901
    [Abstract] [Full Text] [Related]

  • 5. Do chronic inhaled steroids alone or in combination with a bronchodilator prolong life in chronic obstructive pulmonary disease patients?
    Sin DD, Man SF.
    Curr Opin Pulm Med; 2007 Mar; 13(2):90-7. PubMed ID: 17255798
    [Abstract] [Full Text] [Related]

  • 6. [Inhaled corticosteroids in patients with COPD: maintain current guidelines].
    Heijdra YF.
    Ned Tijdschr Geneeskd; 2007 Oct 06; 151(40):2195-7. PubMed ID: 17969568
    [Abstract] [Full Text] [Related]

  • 7. Mono- and combination therapy of long-acting bronchodilators and inhaled corticosteroids in advanced COPD.
    Ohar JA, Donohue JF.
    Semin Respir Crit Care Med; 2010 Jun 06; 31(3):321-33. PubMed ID: 20496301
    [Abstract] [Full Text] [Related]

  • 8. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.
    Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Yates JC, Vestbo J, TORCH investigators.
    N Engl J Med; 2007 Feb 22; 356(8):775-89. PubMed ID: 17314337
    [Abstract] [Full Text] [Related]

  • 9. Management of chronic obstructive pulmonary disease: moving beyond the asthma algorithm.
    Gordon E, Lazarus SC.
    J Allergy Clin Immunol; 2009 Nov 22; 124(5):873-80; quiz 881-2. PubMed ID: 19895979
    [Abstract] [Full Text] [Related]

  • 10. Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study.
    Celli BR, Thomas NE, Anderson JA, Ferguson GT, Jenkins CR, Jones PW, Vestbo J, Knobil K, Yates JC, Calverley PM.
    Am J Respir Crit Care Med; 2008 Aug 15; 178(4):332-8. PubMed ID: 18511702
    [Abstract] [Full Text] [Related]

  • 11. Clinical course of chronic obstructive pulmonary disease: review of therapeutic interventions.
    Anzueto A.
    Am J Med; 2006 Oct 15; 119(10 Suppl 1):46-53. PubMed ID: 16996899
    [Abstract] [Full Text] [Related]

  • 12. Optimizing maintenance therapy for chronic obstructive pulmonary disease: strategies for improving patient-centered outcomes.
    Hanania NA.
    Clin Ther; 2007 Oct 15; 29(10):2121-33. PubMed ID: 18042470
    [Abstract] [Full Text] [Related]

  • 13. Methodological issues in therapeutic trials of COPD.
    Suissa S, Ernst P, Vandemheen KL, Aaron SD.
    Eur Respir J; 2008 May 15; 31(5):927-33. PubMed ID: 18216056
    [Abstract] [Full Text] [Related]

  • 14. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
    Sobieraj DM, White CM, Coleman CI.
    Clin Ther; 2008 Aug 15; 30(8):1416-25. PubMed ID: 18803985
    [Abstract] [Full Text] [Related]

  • 15. The role of corticosteroids in chronic obstructive pulmonary disease.
    Calverley PM.
    Semin Respir Crit Care Med; 2005 Apr 15; 26(2):235-45. PubMed ID: 16088440
    [Abstract] [Full Text] [Related]

  • 16. Mega trials in COPD--clinical data analysis and design issues.
    Suissa S, Ernst P.
    Pneumonol Alergol Pol; 2011 Apr 15; 79(3):227-31. PubMed ID: 21509736
    [Abstract] [Full Text] [Related]

  • 17. Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease.
    Sin DD, Wu L, Anderson JA, Anthonisen NR, Buist AS, Burge PS, Calverley PM, Connett JE, Lindmark B, Pauwels RA, Postma DS, Soriano JB, Szafranski W, Vestbo J.
    Thorax; 2005 Dec 15; 60(12):992-7. PubMed ID: 16227327
    [Abstract] [Full Text] [Related]

  • 18. Optimizing treatment of chronic obstructive pulmonary disease: an assessment of current therapies.
    Wise RA, Tashkin DP.
    Am J Med; 2007 Aug 15; 120(8 Suppl 1):S4-13. PubMed ID: 17678942
    [Abstract] [Full Text] [Related]

  • 19. Inhaled corticosteroids in chronic obstructive pulmonary disease: a review.
    Telenga ED, Kerstjens HA, Postma DS, Ten Hacken NH, van den Berge M.
    Expert Opin Pharmacother; 2010 Feb 15; 11(3):405-21. PubMed ID: 20102305
    [Abstract] [Full Text] [Related]

  • 20. Effects of inhaled corticosteroids in monotherapy or combined with long-acting {beta}2-agonists on mortality among patients with chronic obstructive pulmonary disease.
    Cyr MC, Beauchesne MF, Lemière C, Aaron SD, Blais L.
    Ann Pharmacother; 2010 Apr 15; 44(4):613-22. PubMed ID: 20233915
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.